Genetic variability of platelet glycoprotein Ibα gene
Margareth C. Ozelo
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorDevanira S.P. Costa
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorLucia H. Siqueira
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorTania M.F. Machado
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorVagner Castro
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorMarilda S. Gonçalves
Department of Pharmacology, Federal University of Bahia, Salvador, Bahia, Brazil
Search for more papers by this authorRaimundo C. Menezes
Evandro Chagas Institute, Belém, Pará, Brazil
Search for more papers by this authorJoyce M. Annichino-Bizzacchi
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorFernando F. Costa
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorCorresponding Author
Valder R. Arruda
Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 3516 Civic Center Blvd., ARC-302F, Philadelphia, PA 19104Search for more papers by this authorMargareth C. Ozelo
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorDevanira S.P. Costa
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorLucia H. Siqueira
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorTania M.F. Machado
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorVagner Castro
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorMarilda S. Gonçalves
Department of Pharmacology, Federal University of Bahia, Salvador, Bahia, Brazil
Search for more papers by this authorRaimundo C. Menezes
Evandro Chagas Institute, Belém, Pará, Brazil
Search for more papers by this authorJoyce M. Annichino-Bizzacchi
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorFernando F. Costa
Hematology and Hemotherapy Center, State University of Campinas, Campinas, São Paulo, Brazil
Search for more papers by this authorCorresponding Author
Valder R. Arruda
Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 3516 Civic Center Blvd., ARC-302F, Philadelphia, PA 19104Search for more papers by this authorAbstract
Platelet membrane glycoprotein (GP) Ibα is a critical component of platelet adhesion complex to subendothelium structures following tissue injury or pathological surfaces, such as atherosclerotic plaques. Polymorphisms of the GPIbα gene have been associated with a high risk for occlusive vascular disease, and its distribution varies considerably among distinct populations. These polymorphisms comprise the human platelet antigen (HPA)-2 system, the −5C/T dimorphism of the Kozak sequence, and the variable number of tandem 39-bp repeats (VNTR). Here we report the prevalence of the GPIbα gene polymorphisms among Brazilians, a highly ethnically diverse population. We analyzed 492 subjects of European, African, or Indigenous origin. It was possible to determine ten distinct haplotypes. The most common (∽40%) haplotype was the Kozak-TT/HPA-2aa/VNTR-CC for both Caucasian and African descent. However, among Indigenous, Kozak-TT/HPA-2aa/VNTR-CC and Kozak-TC/HPA-2aa/VNTR-CC were equally present. Although a strong linkage disequilibrium between VNTR and HPA-2 polymorphism had also been observed, here we determined incomplete linkage disequilibrium in 10% of subjects from all ethnic groups. VNTR-E, a rare variant lacking the 39-bp repeat, was identified in two unrelated subjects, and functional platelet studies revealed no abnormalities. The VNTR-A allele, the largest variant containing four copies of the repeats, was not identified in this population. However, homozygosity for the VNTR-A allele (Kozak-TT/HPA-2aa/VNTR-AA) was determined in two distinct species of nonhuman primates. These results suggest a greater complex evolutionary mechanism in the macroglycoprotein region of the GPIbα gene and may be useful in the design of gene–disease association studies for vascular disease. Am. J. Hematol. 77:107–116, 2004. © 2004 Wiley-Liss, Inc.
REFERENCES
- 1Lopez J, Berndt M. The GPIb-IX-V complex. In: A Michelson, editor. Platelets. San Diego: Elsevier Science; 2002. p 85–104.
- 2Lopez J, Andrews R, Afshar-Kharghan V, Berndt M. Bernard-Soulier syndrome. Blood 1998; 91: 4397–4418.
- 3Ware J, Russell S, Ruggeri Z. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci USA 2000; 97: 2803–2808.
- 4Ruggeri Z. Platelet in atherosclerosis. Nat Med 2002; 8: 1227–1234.
- 5Afshar-Kharghan V, Li C, Khoshnevis-Asl M, Lopez J. Kozak sequence polymorphism of the glycoprotein (GP) Ib alpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V. Blood 1999; 94: 186–191.
- 6Cadroy Y, Sakariassen K, Charlet J, et al. Role of four platelet glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood 2001; 98: 3159–3161.
- 7Moroi M, Jung S, Yoshida N. Genetic polymorphism of platelet glycoprotein Ib. Blood 1984; 64: 622.
- 8Lopez J, Ludwig E, McCarthy B. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13 amino acid sequence in the mucin-like macroglycopeptide region. J Biol Chem 1992; 267: 10055–10061.
- 9Ishida F, Furihata K, Ishida K, et al. The largest variant of platelet glycoprotein Iba has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine. Blood 1995; 86: 1356.
- 10Muckian C, Hillmann A, Kenny D, Shields D. A novel variant of the platelet glycoprotein Ib alpha macroglycopeptide region lacks copies of the perfect 13 amino acid repeat. Thromb Haemost 2000; 83: 513–514.
- 11Kuijpers R, Faber N, Cuypers H, Ouwehand W, von dem Borne A. NH2-Terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine 145 amino acid polymorphism, which is associated with the HPA-2 (ko) alloantigens. J Clin Invest 1992; 89: 381–384.
- 12Simsek S, Bleeker P, van der Schoot C, von dem Borne A. Association of variable number of tandem repeats (VNTR) in glycoprotein Ib alpha and HPA-2 alloantigens. Thromb Haemost 1994; 72: 757–761.
- 13Aramaki K, Reiner A. A novel isoform of platelet glycoprotein Ib alpha is prevalent among African Americans. Am J Hematol 1999; 60: 77–79.
10.1002/(SICI)1096-8652(199901)60:1<77::AID-AJH15>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- 14Corral J, Gonzales-Conejero R, Lozano M, Rivera J, Vicente V. New alleles of the platelet glycoprotein Ib alpha gene. Br J Haematol 1998; 103: 997–1003.
- 15Kaski S, Kekomaki R, Partanen J. Systemic screening for genetic polymorphism in human glycoprotein Ib alpha. Immunogenetics 1996; 44: 170–176.
- 16Jilma-Stohlawetz P, Homoncik M, Jilma B, et al. Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 2003; 120: 652–655.
- 17Baker R, Eikebon J, Lofthouse E, et al. Platelet glycoprotein Ib alpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001; 98: 36–40.
- 18Gonzales-Conejero R, Lozano M, Rivera J, et al. Polymorphism of platelet membrane glycoprotein Ib alpha associated with arterial thrombotic disease. Blood 1998; 92: 2771–2776.
- 19Murata M, Matsubara Y, Kawano K, et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997; 96: 3281–3286.
- 20Simmons R, Hermilda J, Rezende S, Lane D. Haemostatic genetic risk factors in arterial thrombosis. Thromb Haemost 2001; 86: 374–385.
- 21Sonoda A, Murata M, Ito T, et al. Association between platelet glycoprotein Ib alpha genotype and ischemic cerebrovascular disease. Stroke 2000; 31: 493–397.
- 22Corral J, Lozano M, Gonzales-Conejero R, et al. A common polymorphism flanking the ATG initiator codon of GPIb alpha does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 2000; 83: 23–28.
- 23Frank M, Reiner A, Schwartz S, et al. The Kozak sequence polymorphism of platelet glycoprotein Ib alpha and risk of nonfatal myocardial infarction and nonfatal stroke in young women. Blood 2001; 97: 875–879.
- 24Ishida F, Ito T, Takei M, et al. Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alfa with human platelet antigen-2 and variable number of tandem repeats polymorphisms, and its relationship with coronary artery disease. Br J Haematol 2000; 111: 1247–1249.
- 25Santoso S, Zimmermann P, Sachs U, Gardemann A. The impact of the Kozak sequence polymorphism of the glycoprotein Ib alpha gene on the risk and extent of coronary heart disease. Thromb Haemost 2002; 87: 345–346.
- 26Anand S, Yusuf S, Devanesen S, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE). Lancet 2000; 356: 279–284.
- 27Dowling N, Austin H, Dilley A, et al. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost 2003; 1: 80–87.
- 28Kniffin D Jr, Baron J, Barrett J, Birkmeyer D, Anderson F Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861–866.
- 29Parra F, Amado R, Lambertucci J, et al. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003; 100: 177–182.
- 30Curtin P. The Slave Atlantic trade: a census. Milwaukee: University of Wisconsin Press; 1969.
- 31Black F, Salzano F, Layrisse Z, et al. Restriction persistence of polymorphisms of HLA and other blood genetic traits in Parakanas Indians of Brazil. Am J Phys Anthropol 1980; 52: 119–132.
- 32Castro V, Origa A, Goncalves M, et al. Frequencies of platelet-specific alloantigens systems 1 to 5 in three distinct ethnic groups in Brazil. Eur J Immunogenet 1999; 26: 355–360.
- 33Budde U, Drewke E, Mainusch K, Schneppenheim R. Laboratory diagnosis of congenital von Willebrand disease. Semin Thromb Hemost 2002; 28: 173–190.
- 34Dean A, Dean J, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention; 1994.
- 35Duncan B, Schmidt S, Polanczyk C, Mengue S. High mortality rates among Brazilians adult populations as an international comparison. Rev Assoc Med Bras 1992; 38: 138–144.
- 36Siqueira Neto J, Santos A, Fabio SRC, Sakamoto A. Ischemic stroke in patients under age 45. Stroke 1996; 10: 113–124.
- 37Voetsch B, Damasceno B, Camargo E, et al. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost 2000; 83: 229–233.
- 38Tishkoff S, Williams S. Genetic analysis of African populations: human evolution and complex disease. Nature Rev 2002; 3: 611–621.
- 39Roos R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 115–126.
- 40Cavalli-Sforza L, Piazza A, Menozzi P, Mountain J. Reconstruction of human evolution: bringing together genetic, archeological, and linguistic data. Proc Natl Acad Sci USA 1988; 85: 6002–6006.
- 41Arruda V, Siqueira L, Chiaparini L, et al. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430–1433.
- 42Arruda V, Siqueira L, Goncalves M, et al. Prevalence of the mutation C677 to T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 1998; 78: 332–335.
10.1002/(SICI)1096-8628(19980724)78:4<332::AID-AJMG5>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- 43Arruda V, von Zuben P, Soares M, et al. Very low incidence of Arg506 to Gln mutation in the factor V gene among the Amazonian and the Brazilian black populations. Thromb Haemost 1996; 75: 860–861.
- 44Osawa M, Kaneko M, Horiuchi H, et al. Evolution of the cystatin B gene: implications for the origin of its variable dodecamer tandem repeat in humans. Genomics 2003; 81: 78–84.